Literature DB >> 28698902

[Radiotherapy enhances the effect of PD-1 checkpoint inhibitors].

René Baumann1, Jürgen Dunst2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28698902     DOI： 10.1007/s00066-017-1179-9

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

Review 1.  Role of Local Radiation Therapy in Cancer Immunotherapy.

Authors:  Sandra Demaria; Encouse B Golden; Silvia C Formenti
Journal:  JAMA Oncol       Date:  2015-12       Impact factor: 31.777

2.  Immunologic correlates of the abscopal effect in a patient with melanoma.

Authors:  Michael A Postow; Margaret K Callahan; Christopher A Barker; Yoshiya Yamada; Jianda Yuan; Shigehisa Kitano; Zhenyu Mu; Teresa Rasalan; Matthew Adamow; Erika Ritter; Christine Sedrak; Achim A Jungbluth; Ramon Chua; Arvin S Yang; Ruth-Ann Roman; Samuel Rosner; Brenna Benson; James P Allison; Alexander M Lesokhin; Sacha Gnjatic; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

3.  Pembrolizumab for the treatment of non-small-cell lung cancer.

Authors:  Edward B Garon; Naiyer A Rizvi; Rina Hui; Natasha Leighl; Ani S Balmanoukian; Joseph Paul Eder; Amita Patnaik; Charu Aggarwal; Matthew Gubens; Leora Horn; Enric Carcereny; Myung-Ju Ahn; Enriqueta Felip; Jong-Seok Lee; Matthew D Hellmann; Omid Hamid; Jonathan W Goldman; Jean-Charles Soria; Marisa Dolled-Filhart; Ruth Z Rutledge; Jin Zhang; Jared K Lunceford; Reshma Rangwala; Gregory M Lubiniecki; Charlotte Roach; Kenneth Emancipator; Leena Gandhi
Journal:  N Engl J Med       Date:  2015-04-19       Impact factor: 91.245

4.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Authors:  Martin Reck; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Melanie A Leiby; Gregory M Lubiniecki; Yue Shentu; Reshma Rangwala; Julie R Brahmer
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

5.  Radiation therapy to convert the tumor into an in situ vaccine.

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-11-15       Impact factor: 7.038

6.  Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Authors:  Eric A Reits; James W Hodge; Carla A Herberts; Tom A Groothuis; Mala Chakraborty; Elizabeth K Wansley; Kevin Camphausen; Rosalie M Luiten; Arnold H de Ru; Joost Neijssen; Alexander Griekspoor; Elly Mesman; Frank A Verreck; Hergen Spits; Jeffrey Schlom; Peter van Veelen; Jacques J Neefjes
Journal:  J Exp Med       Date:  2006-04-24       Impact factor: 14.307
  6 in total
  3 in total

1.  Use of psychosocial services by lung cancer survivors in Germany : Results of a German multicenter study (LARIS).

Authors:  Martin Eichler; Marlene Hechtner; Beatrice Wehler; Roland Buhl; Jan Stratmann; Martin Sebastian; Heinz Schmidberger; Cornelius Kortsik; Ursula Nestle; Hubert Wirtz; Thomas Wehler; Maria Blettner; Susanne Singer
Journal:  Strahlenther Onkol       Date:  2019-07-10       Impact factor: 3.621

2.  Polyfunctionality of CD4+ T lymphocytes is increased after chemoradiotherapy of head and neck squamous cell carcinoma.

Authors:  J Doescher; S Jeske; S E Weissinger; C Brunner; S Laban; E Bölke; T K Hoffmann; T L Whiteside; P J Schuler
Journal:  Strahlenther Onkol       Date:  2018-04-16       Impact factor: 3.621

3.  Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.

Authors:  Heinz Schmidberger; Matthias Rapp; Anne Ebersberger; Silla Hey-Koch; Carmen Loquai; Stephan Grabbe; Arnulf Mayer
Journal:  Strahlenther Onkol       Date:  2018-10-08       Impact factor: 3.621
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.